Site Search
Site Search
Displaying results 131 - 140 of 893
We’re living longer. What does that mean for existing vaccine strategies?
VITAL are tallying the burden of infectious diseases in ageing adults to figure out the best strategies to keep people healthier for longer.
Alzheimer’s: visual assessment of [18F]flutemetamol PET can reveal not only presence but also extent and location of amyloid
AMYPAD researchers have shown that a ‘visual read’ of PET scans using radioactive diagnostic tracer flutemetamol can go beyond simple yes-or-no determination of the presence of Alzheimer’s hallmark protein.
Are there differences in the brains of autistic men and women?
New research by the AIMS-2-TRIALS project could shed light on the mechanisms underlying sex differences in autism.
Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects
Safety and immunogenicity data on the Johnson & Johnson vaccine technology was gathered during IMI EBOVAC clinical studies.
TRIC-TB starts clinical trial of anti-TB drug booster
If approved for use, BVL-GSK098 could allow doctors to reduce the efficacious dose of two potent drugs used to treat tuberculosis, along with the side effects they cause.
New vaccine technologies wouldn’t be possible without collaboration
Vaccines based on brand new delivery systems or manufacturing technologies need an all-hands approach.
Focus on: rare diseases
Science has tended to neglect diseases that affect small numbers of people, but that is changing.
Treatment tracker: COVID-19 therapeutics research makes progress
News from IMI’s COVID-19 therapeutics projects, launched in the wake of the pandemic outbreak.
How Europe can get better at treating rare diseases
Experts from the IMI Scientific Committee weigh in on what needs to happen to speed up rare disease research.
